With a commitment to innovation, AFT Pharmaceuticals develops, licenses and sells a wide range of products to help improve the health and wellbeing of people.
About AFT Pharmaceuticals.
Read More
Pharmaceuticals
with a difference
Browse latest news
We develop, license, and sell pharmaceutical products in Australasia and around the world. Check out our latest news.
Read More
Our range of innovative products
Learn more about our range of products.
Read More
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Read More
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Read More
Our range of innovative products
Learn more about our range of products
Browse our products
Please select your region below to view products
Our Initiatives
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Our Initiatives
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Financial Results 2023: AFT declares maiden dividend; record revenue
Financial Results for the 12 Months to 31st of March 2023
Read More
AFT Pharmaceuticals to announce full year results on Monday May 22 2023
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Monday May 22 2023 its full year results for the year ended March 31 2023.
Read More
US FDA sets PDUFA date for Maxigesic IV®
AFT Pharmaceuticals today announces the US Food and Drug Administration has set 17 October 2023 as the date by which it expects to respond to AFT’s application to register Maxigesic IV in the US.
Read More